Advances in recurrence risk assessment of gastrointestinal stromal tumor / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
; (12): 1138-1143, 2022.
Article
en Zh
| WPRIM
| ID: wpr-971225
Biblioteca responsable:
WPRO
ABSTRACT
Identification of prognosis-related risk factors and accurate assessment of risk stratification in patients with gastrointestinal stromal tumor (GIST) is of great significance not only for establishing a reliable prognostic model and developing a follow-up plan but also for selecting potential populations benefiting from neoadjuvant therapies. Although several risk stratification models have been established, it is still challenging to accurately assess patients' risk of recurrence, and the performance of these prediction models still needs to be improved. This review focused on the latest studies in recurrence risk assessment for GIST patients, and summarized potential predictive markers and recurrence risk models related to tumor-related characteristic parameters, novel laboratory examinations, radiological imaging signatures and molecular pathological features, which could provide a reference for accurate risk stratification and individualized targeted therapies for GIST patients.
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Pronóstico
/
Estudios Retrospectivos
/
Factores de Riesgo
/
Medición de Riesgo
/
Tumores del Estroma Gastrointestinal
/
Recurrencia Local de Neoplasia
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Gastrointestinal Surgery
Año:
2022
Tipo del documento:
Article